TY - PAT
T1 - Inhibitor of integrin for the treatment or prevention of tumours
AU - De Maria Marchiano, Ruggero
AU - Haas, Tobias Longin
AU - Vitiani, Lucia Ricci
AU - Biffoni, Mauro
PY - 2013/11/8
Y1 - 2013/11/8
N2 - The present invention relates to the field of tumour therapy, in particular to the identification of new molecules for tumour suppression, therapy and/or prevention, to compositions comprising the same and to medical treatments comprising administration of said compounds for the treatment, suppression and/or prevention of tumours.
Furthermore, the present invention relates to inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours, to composition comprising inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours and to medical treatments comprising administering said inhibitors or compositions to a patient in need thereof, for the treatment, suppression and/or prevention of tumours.
AB - The present invention relates to the field of tumour therapy, in particular to the identification of new molecules for tumour suppression, therapy and/or prevention, to compositions comprising the same and to medical treatments comprising administration of said compounds for the treatment, suppression and/or prevention of tumours.
Furthermore, the present invention relates to inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours, to composition comprising inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours and to medical treatments comprising administering said inhibitors or compositions to a patient in need thereof, for the treatment, suppression and/or prevention of tumours.
KW - Integrin alpha 7
KW - Integrin alpha 7
UR - http://hdl.handle.net/10807/116774
M3 - Patent
M1 - WO2014072940A1
ER -